Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jan Ruprecht

3PUBLICATIONS

29CO-AUTHORS

Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesGene and molecular therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|May 05, 2026

Development of High-Affinity CHD1 Chromodomain Inhibitors.

|Oct 30, 2025

From Pharmacophore to Warhead: NAD<sup>+</sup>-Targeting Triazoles as Mechanism-Based Sirtuin Inhibitors.

Florian Friedrich, Marat Meleshin, Niklas Papenkordt

|Jun 17, 2025

Structure-Guided Design of a KMT9 Inhibitor Prodrug with Cellular Activity.

Sheng Wang, Nicolas P F Barthes, Sylvia Urban

Pageof 1

Frequent Collaborators

3 joint publications

Manfred Jung

2 joint publications

Sheng Wang

2 joint publications

Stefan Günther

2 joint publications

Bernhard Breit

2 joint publications

Florian Friedrich

2 joint publications

Niklas Papenkordt

1 joint publications

Nicolas P F Barthes

1 joint publications

Sebastian O Klein

1 joint publications

Marat Meleshin

1 joint publications

Lena Gaitzsch

Frequent Collaborators

3 joint publications

Manfred Jung

2 joint publications

Sheng Wang

2 joint publications

Stefan Günther

2 joint publications

Bernhard Breit

Top Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on : Oct 26, 2015

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on : Sep 26, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

See more related videos

Top Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on : Oct 26, 2015

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on : Sep 26, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

See more related videos